The US Department of Justice (DOJ) closed its probe into a devicemaker’s failure to inform the US Food and Drug Administration (FDA) it had withdrawn its powder wound dressing product from the market.
COLUMBIA, Md., March 19, 2019 /PRNewswire/ -- ACell, Inc. today announced that it has entered into an exclusive distribution agreement with MyungMoon Bio Co. Ltd. MyungMoon is a leading manufacturer ...
BALTIMORE (WJZ) -- ACell, Inc. (ACell) a Maryland-based medical device manufacturer, pleaded guilty to charges relating to its MicroMatrix powder wound-dressing product. ACell entered a guilty plea to ...
ACell, which makes medical devices for wounds and soft tissue surgical defects, announced terms for its IPO on Monday. The Columbia, MD-based company plans to raise $75 million by offering 5 million ...
COLUMBIA, Md., April 8, 2019 /PRNewswire/ -- ACell, Inc. today announced that it has entered into an exclusive long-term product supply and distribution agreement with First Horizon, LLC and Weihai ...
The company knew in January 2012 that some of its MicroMatrix devices were tainted with high endotoxin levels, but failed to notify the FDA. Medical device maker ACell Inc. has pleaded guilty and will ...
COLUMBIA, Md., June 11, 2019 /PRNewswire/ -- ACell, Inc. today announced that it has reached final settlement agreements with the United States Attorney's Office for the District of Maryland and three ...
COLUMBIA, Md., Sept. 4, 2019 /CNW/ -- ACell, Inc. and Southmedic today announced the Canadian launch of the Gentrix TM Surgical Matrix family of devices, comprised of ACell's platform MatriStem UBM™ ...
Integra LifeSciences Holdings Corp. completed the previously-disclosed acquisition of ACell Inc. the Princeton-based medical technology company announced Jan. 20. “Acquiring ACell and its proprietary ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Columbia, MD - (January 11, 2016) – ACell, Inc. today announced that it has named Patrick (Pat) McBrayer President and Chief Executive Officer. McBrayer succeeds Kyle Kerbawy, who will remain as ...
ACell Inc. set terms of its initial public offering, in which the Maryland-based regenerative medicine company focused on severe wounds treatment looks to raise up to $80 million and be valued at up ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results